Showing 1 - 10 of 5,017
This study aims to evaluate the effects of selected key factors on health outcomes. Unfortunately, statistical reporting in this field is not harmonized, and in some countries it is completely absent. For this reason, valuable information for health determinant analysis may be lacking or...
Persistent link: https://www.econbiz.de/10014516195
expectancy and decreases the mortality rate. The positive relationship between clean energy and human health suggests that clean … energy helps to control chronic diseases thus leading to high life expectancy, low mortality, and fewer incidence of … tuberculosis. It is further concluded that economic growth, trade, and urbanization also produce better health outcomes. The …
Persistent link: https://www.econbiz.de/10012507100
Persistent link: https://www.econbiz.de/10014478657
From 1850 to 2000, in Western European countries life expectancy rose from 30–40 to 80 years and the average number of children per woman fell from 4 to 5 children to slightly more than one. To gauge the economic consequences of these demographic trends, we implement an overlapping generations...
Persistent link: https://www.econbiz.de/10011865181
Attainment of 70 years life expectancy by 2020 is one of the millennium development goals in Nigeria. This study examined the socio-economic determinants of life expectancy in Nigeria using data from 1980 - 2011. Judging from the endogeneity feature of the variables, A VAR and VECM frameworks...
Persistent link: https://www.econbiz.de/10010530043
In order to improve transparency and stabilise health care costs, several countries have decided to reform their healthcare system on the basis of diagnosis-related groups (DRG). DRGs are not only used for classifying medical treatments, but also for case-based reimbursement, hence induce active...
Persistent link: https://www.econbiz.de/10010414289
Persistent link: https://www.econbiz.de/10013252716
One of the main goals at the European level is that healthcare systems must be accessible but at the same time cost-effective and sustainable in the long term. The implementation of eHealth is one way to contribute to this goal. The presented paper is focused on the evaluation of the usage of...
Persistent link: https://www.econbiz.de/10013205969
The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines Agency (EMA) search engine showed 54 authorized biosimilars. Biosimilars...
Persistent link: https://www.econbiz.de/10012417671
This article sheds light on the role of subnational governments in health systems across OECD countries. The views in this article show a move away from traditional measures of decentralisation, such as the share of subnational government expenditure of total expenditure, to measures capturing a...
Persistent link: https://www.econbiz.de/10012418967